Eli Lilly and Co. may have to wait an extra year or more to launch a once-a-day insulin for diabetics after a rival drugmaker said Lilly's plans violate the patents it holds on the drug Lantus.
http://ift.tt/1a7xXH4
http://ift.tt/1a7xXH4
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment